Bausch Health Cos Basic EPS 2010-2024 | BHC

Bausch Health Cos basic eps from 2010 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
Bausch Health Cos Annual Basic EPS
2024 $-0.13
2023 $-1.62
2022 $-0.62
2021 $-2.64
2020 $-1.58
2019 $-5.08
2018 $-11.81
2017 $6.86
2016 $-6.94
2015 $-0.85
2014 $2.63
2013 $-2.70
2012 $-0.38
2011 $0.52
2010 $-1.06
2009 $1.11
Bausch Health Cos Quarterly Basic EPS
2024-12-31 $0.24
2024-09-30 $-0.23
2024-06-30 $0.03
2024-03-31 $-0.17
2023-12-31 $-0.11
2023-09-30 $-1.03
2023-06-30 $0.07
2023-03-31 $-0.55
2022-12-31 $-1.13
2022-09-30 $1.10
2022-06-30 $-0.40
2022-03-31 $-0.19
2021-12-31 $0.21
2021-09-30 $0.52
2021-06-30 $-1.66
2021-03-31 $-1.71
2020-12-31 $-0.43
2020-09-30 $0.20
2020-06-30 $-0.92
2020-03-31 $-0.43
2019-12-31 $-4.30
2019-09-30 $-0.14
2019-06-30 $-0.49
2019-03-31 $-0.15
2018-12-31 $-0.96
2018-09-30 $-1.00
2018-06-30 $-2.49
2018-03-31 $-7.36
2017-12-31 $1.46
2017-09-30 $3.71
2017-06-30 $-0.11
2017-03-31 $1.80
2016-12-31 $-1.49
2016-09-30 $-3.49
2016-06-30 $-0.88
2016-03-31 $-1.08
2015-12-31 $-1.13
2015-09-30 $0.14
2015-06-30 $-0.15
2015-03-31 $0.29
2014-12-31 $1.50
2014-09-30 $0.82
2014-06-30 $0.38
2014-03-31 $-0.07
2013-12-31 $0.27
2013-09-30 $-2.92
2013-06-30 $0.04
2013-03-31 $-0.09
2012-12-31 $-0.30
2012-09-30 $0.03
2012-06-30 $-0.07
2012-03-31 $-0.04
2011-12-31 $0.18
2011-09-30 $0.13
2011-06-30 $0.19
2011-03-31 $0.02
2010-12-31 $0.02
2010-09-30 $-1.27
2010-06-30 $0.21
2010-03-31 $-0.02
2009-12-31 $0.46
2009-09-30 $0.25
2009-06-30 $0.15
2009-03-31 $0.25
Sector Industry Market Cap Revenue
Medical MED-GENERIC DRG $1.958B $9.625B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) IL $17.711B 6.48
Dr Reddy's Laboratories (RDY) IN $11.545B 22.02
BridgeBio Pharma (BBIO) US $7.291B 0.00
Supernus Pharmaceuticals (SUPN) US $1.817B 16.90
Amphastar Pharmaceuticals (AMPH) US $1.134B 6.86
Taysha Gene Therapies (TSHA) US $0.494B 0.00
Personalis (PSNL) US $0.341B 0.00
Assembly Biosciences (ASMB) US $0.087B 0.00
Sol-Gel Technologies (SLGL) IL $0.022B 0.00
Evoke Pharma (EVOK) US $0.004B 0.00
Teligent (TLGT) US $0.000B 0.00